News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gyros AB Expands Asian Distribution to Singapore


6/6/2012 10:02:42 AM

Uppsala, Sweden and Singapore, 6 June 2012: Gyros AB, a leader in utilization of microfluidic technologies to miniaturize and automate immunoassays, announced today that Bio Laboratories Pte Ltd (www.biolab.com.sg) has become sole distributor for the company’s nanoliter-scale immunoassay platform in Singapore. The Gyros platform (www.gyros.com) is used by major biopharmaceutical companies and their service providers worldwide to improve productivity and efficiency during the development of biotherapeutics and vaccines, boosting time-critical workflows and helping to meet regulatory demands.

“We are very pleased to expand our reach in Asia through this new partnership with Bio Laboratories, which provides a valuable addition to our recently announced collaboration with GE Healthcare for distribution in Japan, China, Taiwan and Hong Kong,” commented Erik Walldén, CEO, Gyros. “As our immunoassay platform increases in acceptance within the biopharmaceutical industry, it is ever more vital that we have an experienced and respected network of distributors to ensure the highest possible standards of service and support for our customers.”

Benny Wee, Managing Director, Bio Laboratories, said, “The Gyros immunoassay platform is an excellent addition to our extensive range of distribution agreements with high quality, innovative analytical instrument providers. We are delighted to be able to now offer Gyros’ products to the biopharmaceutical industry in Singapore.”

About Gyros AB www.gyros.com

Gyros AB is the world leader in utilization of microfluidic technologies to miniaturize and automate immunoassays. The Gyros™ immunoassay platform increases productivity and efficiency during development of biotherapeutics and vaccines, saving time and labor. Major biopharmaceutical companies and their service providers utilize the Gyros platform to boost time-critical workflows and meet increasing regulatory demands.

Spanning the entire spectrum of immunoassays, the platform cuts the time to result significantly. Faster development times, and unattended running of assays at nanolitre scale, save labor and sample. The ease of assay transfer between sites and from development to regulated environments is unsurpassed in the industry.

The company has around 60 employees, based at its headquarters in Uppsala, Sweden and at regional sales and support offices in the USA and Europe, and a growing network of distributors.

About Bio Laboratories Pte Ltd

Bio Laboratories is a leading distributor of medical, scientific and life science products in Singapore. We focus on serving customers through the innovative and responsible application of science and technology. Bio Laboratories prides itself on its efficient service and technical service support.

With its suppliers as business partners, one of Bio Laboratories goals is to bring new technologies into the market which will benefit its customers and in the process grow its overall business. This is the reason for our existence. We believe in long-term partnership with our customers and business partners based on mutual trust and respect.

Enquiries:

For Gyros AB

Lorna Cuddon

Zyme Communications Ltd

Tel: +44 (0)7811 996 942

Email: lorna.cuddon@zymecommunications.com

Skype: lorna.cuddon

Web: www.zymecommunications.com

Twitter: zymecomms

For Bio Laboratories Pte Ltd

Benny Wee

Managing Director

Tel: +65 6846 7577

Email: benny_wee@biolab.com.sg


Read at BioSpace.com


comments powered by Disqus
Gyros AB
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES